MMSI (Merit Medical Systems) EPS (Basic): $2.35 (TTM As of Mar. 2026)

What is Merit Medical Systems EPS (Basic)?

Merit Medical Systems MMSI +2.82% 83 EPS (Basic) is $2.35 as of Mar. 2026. GuruFocus rates MMSI with a GF Score™ of 83/100 and a GF Value™ of $96.68 (Modestly Undervalued).

Merit Medical Systems's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $0.69. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $2.35.

Merit Medical Systems's EPS (Diluted) for the three months ended in Mar. 2026 was $0.68. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $2.31.

Merit Medical Systems's EPS without NRI for the three months ended in Mar. 2026 was $0.94. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.91.

During the past 12 months, Merit Medical Systems's average EPS without NRIGrowth Rate was 19.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Merit Medical Systems's highest 3-Year average EPS without NRI Growth Rate was 196.20% per year. The lowest was -14.90% per year. And the median was 10.80% per year.

Merit Medical Systems (NAS:MMSI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Merit Medical Systems EPS (Basic) Related Terms

Merit Medical Systems EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems EPS (Basic) Chart

Merit Medical Systems Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

0.86

1.31

1.64

2.07

2.17

Merit Medical Systems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															0.51	0.55	0.47	0.64	0.69

83GF Score

Merit Medical Systems Inc MMSI

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Merit Medical Systems EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Merit Medical Systems's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(128.489	-	0)	/	59.158
	=	2.17

Merit Medical Systems's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(40.995	-	0)	/	59.510
	=	0.69

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.35

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $2.35 mean?

Merit Medical Systems (MMSI) has a EPS (Basic) of $2.35 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Merit Medical Systems and its competitors.

Is Merit Medical Systems' EPS (Basic) too high?

Merit Medical Systems' current EPS (Basic) is $2.35. Overall, Merit Medical Systems has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Merit Medical Systems' EPS (Basic) compare to NVST and MMED?

Merit Medical Systems' EPS (Basic) of $2.35 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Merit Medical Systems and its competitors. Merit Medical Systems's current EPS (Basic) is $2.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Merit Medical Systems stock overvalued right now?

Based on GuruFocus' analysis, Merit Medical Systems (MMSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $96.68, compared to a current price of $69.20 — trading 28.4% below its estimated fair value. The current EPS (Basic) is $2.35. Merit Medical Systems' overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Merit Medical Systems (MMSI), the current EPS (Basic) is $2.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (MMSI) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of $69.20 is trading 28.4% below its estimated GF Value™ of $96.68. GuruFocus considers Merit Medical Systems to be Modestly Undervalued.

Key valuation signals for MMSI:

EPS (Basic): $2.35
GF Value™: $96.68 vs. price of $69.20 (28.4% below fair value)
GF Score™: 83/100

No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merit Medical Systems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies NVST MMED ICUI WRBY STVN LMAT XRAY TFX PLSE NNNN ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges MM3:Germany

Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095

Website https://www.merit.com

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

83GF Score

Get the complete analysis for MMSI

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.20

Price

$96.68

GF Value

View MMSI Analysis

See EPS (Basic) data for all stocks →